APrevent is a medical device company founded by a team of international clinically experienced physicians and engineers. Its primary product is an implant for treatment of unilateral vocal fold paralysis (UVFP), which is the first implant on the market that can be adjusted both intra- and postoperatively. AiSpeak is an AI speech recognition software for speech disorder patients developed by APrevent which won first place at the Qualcomm Innovate in Taiwan Challenge (QITC) 2022.